Eating Disorders Trial, Recruiting NCT06144905 Sponsor: Norwegian University of Life Sciences Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT06144905
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with anorexia nervosa (AN):

  • You are female
  • You are between 16 and 50 years old
  • Your BMI is below 18.5 (which is considered underweight)
  • You have been diagnosed with anorexia nervosa according to standard medical guidelines (ICD-10)
  • You are currently being referred to a specialist inpatient programme for nutritional treatment of anorexia nervosa
  • You are able to read and understand Norwegian questionnaires

For healthy comparison participants (control group):

  • You are female
  • You are between 16 and 50 years old
  • Your BMI is between 18.5 and below 27 (considered a normal to slightly above normal weight range)
  • You are able to read and understand Norwegian questionnaires

Who may not be able to join:

  • You have a history of inflammatory bowel disease (such as Crohn's disease or ulcerative colitis), coeliac disease, or have had surgery on your digestive system
  • You have taken antibiotic tablets or capsules in the past two months
  • You have been regularly taking high amounts of probiotic supplements (such as certain yoghurts or supplement capsules containing live bacteria) over the past two months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Siv K Bøhn, PhD, Norwegian University of Life Sciences

Phone: +47 67232502

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Norwegian University of Life Sciences
Registry
ClinicalTrials.gov
Start date
24 September 2023
Est. completion
1 September 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Differences in the fecal microbiota composition; Change in the fecal microbiota composition in patients with anorexia nervosa during the standard care treatment at the clinics for eating disorder.; Change in mental scores during standard care treatment at the clinics for eating disorder; Change in gastrointestinal problems during standard care treatment at the clinics for eating disorder

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov